Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations.
Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations.
复制标题
DOI:
10.1096/fj.202300907
复制
发表时间:
2023-09
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Endometriosis is a common estrogen‐dependent disorder wherein uterine lining tissue (endometrium) is found mainly in the pelvis where it causes inflammation, chronic pelvic pain, pain with intercourse and menses, and infertility. Recent evidence also supports a systemic inflammatory component that underlies associated co‐morbidities, e.g., migraines and cardiovascular and autoimmune diseases. Genetics and environment contribute significantly to disease risk, and with the explosion of omics technologies, underlying mechanisms of symptoms are increasingly being elucidated, although novel and effective therapeutics for pain and infertility have lagged behind these advances. Moreover, there are stark disparities in diagnosis, access to care, and treatment among persons of color and transgender/nonbinary identity, socioeconomically disadvantaged populations, and adolescents, and a disturbing low awareness among health care providers, policymakers, and the lay public about endometriosis, which, if left undiagnosed and under‐treated can lead to significant fibrosis, infertility, depression, and markedly diminished quality of life. This review summarizes endometriosis epidemiology, compelling evidence for its pathogenesis, mechanisms underlying its pathophysiology in the age of precision medicine, recent biomarker discovery, novel therapeutic approaches, and issues around reproductive justice for marginalized populations with this disorder spanning the past 100 years. As we enter the next revolution in health care and biomedical research, with rich molecular and clinical datasets, single‐cell omics, and population‐level data, endometriosis is well positioned to benefit from data‐driven research leveraging computational and artificial intelligence approaches integrating data and predicting disease risk, diagnosis, response to medical and surgical therapies, and prognosis for recurrence. Precision medicine is leading the way to resolving complex clinical challenges and disparities in diagnosing and treating many disorders and recently has been extended to endometriosis, a common, inflammatory disease with heterogenous symptoms and lesion subtypes causing chronic pain and infertility. Integrating complex metadata, high‐resolution omics data, imaging modalities, new surgical paradigms, and electronic health record mining are contributing to improved disease phenotyping, early diagnosis, novel drug discovery, personalized therapies, prognostic indicators, and risk of recurrence, across diverse populations.
登录
查看更多内容
影响因子:
6.7
作者:
Becker, Christian M.;Laufer, Marc R.;Stratton, Pamela;Hummelshoj, Lone;Missmer, Stacey A.;Zondervan, Krina T.;Adamson, G. David
通讯作者:
Adamson, G. David
DOI:
10.1111/j.1471-0528.2008.01878.x
发表时间:
2008-10-01
影响因子:
5.8
作者:
Ballard, K. D.;Seaman, H. E.;Wright, J. T.
通讯作者:
Wright, J. T.
DOI:
10.1056/nejmoa1614814
发表时间:
2017-05-11
期刊:
The New England journal of medicine
影响因子:
--
作者:
Anglesio MS;Papadopoulos N;Ayhan A;Nazeran TM;Noë M;Horlings HM;Lum A;Jones S;Senz J;Seckin T;Ho J;Wu RC;Lac V;Ogawa H;Tessier-Cloutier B;Alhassan R;Wang A;Wang Y;Cohen JD;Wong F;Hasanovic A;Orr N;Zhang M;Popoli M;McMahon W;Wood LD;Mattox A;Allaire C;Segars J;Williams C;Tomasetti C;Boyd N;Kinzler KW;Gilks CB;Diaz L;Wang TL;Vogelstein B;Yong PJ;Huntsman DG;Shih IM
通讯作者:
Shih IM
影响因子:
2.3
作者:
Benacerraf, Beryl R.;Groszmann, Yvette
通讯作者:
Groszmann, Yvette
DOI:
10.1016/j.bpobgyn.2018.01.008
发表时间:
2018-07-01
影响因子:
5.5
作者:
Aerts, Leen;Grangier, Lorraine;Pluchino, Nicola
通讯作者:
Pluchino, Nicola